The GLP-1 drugs (glucagon-like peptide-1 receptor agonists) are developed to treat both type 2 diabetes and obesity by ...
The GLP-1 drugs (glucagon-like peptide-1 receptor agonists) are developed to treat both type 2 diabetes and obesity by correcting hormonal imbalance – stimulating insulin release and suppressing ...
Authorities audit 49 businesses as part of monitoring supply chain of GLP-1 drugs, says centre: Our Bureau, New Delhi Wednesday, April 1, 2026, 14:15 Hrs [IST] The authorities hav ...
India warns of GLP-1 drug risks as Ozempic and Wegovy prices fall, urging prescription-only use and tightening checks on ...
Newsable Asianet News on MSN
GLP-1 drugs for diabetes: India details use, risks, and regulation
The Indian government has released details on GLP-1 drugs for diabetes and obesity, explaining their function and risks. Amid ...
The health ministry warns that GLP-1 drugs for Type 2 Diabetes and obesity should only be taken under medical supervision due ...
12don MSN
'Clinical oversight can lead to…': Govt lists side-effects that can occur from weight-loss drugs
In India, only endocrinologists, internal medicine specialists, and cardiologists can prescribe GLP-1 weight loss drugs.
The Government of India on Thursday released official guidance on the use, risks, and regulation of GLP-1 (glucagon-like ...
The Chosun Ilbo on MSN
Pet longevity industry advances with anti-aging, obesity treatments
The lifespan of companion animals remains shorter compared to humans. Unlike the rapid advancement in medical technology that ...
India drug regulator cracks down on misuse of GLP 1 weight loss drugs, expanding inspections and warnings as demand surges ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results